Home/Immusoft/Robert Sikorski, M.D., Ph.D.
RS

Robert Sikorski, M.D., Ph.D.

Chief Medical Officer

Immusoft

Immusoft Pipeline

DrugIndicationPhase
ISP-001Mucopolysaccharidosis type I (MPS I)Preclinical